Cargando…

Intra-Individual Comparison of (124)I-PET/CT and (124)I-PET/MR Hybrid Imaging of Patients with Resected Differentiated Thyroid Carcinoma: Aspects of Attenuation Correction

SIMPLE SUMMARY: This study evaluates the qualitative and quantitative differences between 124-iodine PET/CT and PET/MR in oncologic patients with differentiated thyroid carcinoma after thyroidectomy. The impact of improved MR-based attenuation correction (AC) using a bone atlas was analysed in PET/M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grafe, Hong, Lindemann, Maike E., Weber, Manuel, Kirchner, Julian, Binse, Ina, Umutlu, Lale, Herrmann, Ken, Quick, Harald H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264885/ https://www.ncbi.nlm.nih.gov/pubmed/35804811 http://dx.doi.org/10.3390/cancers14133040

Ejemplares similares

Quantitative performance of (124)I PET/MR of neck lesions in thyroid cancer patients using (124)I PET/CT as reference
por: Jentzen, Walter, et al.
Publicado: (2018)

Towards fast whole-body PET/MR: Investigation of PET image quality versus reduced PET acquisition times
por: Lindemann, Maike E., et al.
Publicado: (2018)

Evaluation of improved attenuation correction in whole-body PET/MR on patients with bone metastasis using various radiotracers
por: Grafe, Hong, et al.
Publicado: (2020)

Silicon-photomultiplier-based PET/CT reduces the minimum detectable activity of iodine-124
por: Kersting, David, et al.
Publicado: (2021)

Quantitative imaging of (124)I and (86)Y with PET
por: Lubberink, Mark, et al.
Publicado: (2011)

18 F-FDG-PET/MRI in patients with Graves’ orbitopathy.
por: Weber, Manuel, et al.
Publicado: (2021)

Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancer
por: Kersting, David, et al.
Publicado: (2021)

Impact of respiratory motion correction on lesion visibility and quantification in thoracic PET/MR imaging
por: Gratz, Marcel, et al.
Publicado: (2020)

Towards a fast PET/MRI protocol for breast cancer imaging: maintaining diagnostic confidence while reducing PET and MRI acquisition times
por: Jannusch, Kai, et al.
Publicado: (2023)

The diagnostic value of (124)I-PET in patients with differentiated thyroid cancer
por: Phan, Ha T. T., et al.
Publicado: (2008)

Imaging of Musculoskeletal Bacterial Infections by [(124)I]FIAU-PET/CT
por: Diaz, Luis A., et al.
Publicado: (2007)

Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy (124)I PET/CT imaging
por: Jentzen, Walter, et al.
Publicado: (2014)

Impact of improved attenuation correction on 18F-FDG PET/MR hybrid imaging of the heart
por: Lindemann, Maike E., et al.
Publicado: (2019)

Comparison of Imaging Characteristics of (124)I PET for Determination of Optimal Energy Window on the Siemens Inveon PET
por: Yu, A Ram, et al.
Publicado: (2016)

Is the Image Quality of I-124-PET Impaired by an Automatic Correction of Prompt Gammas?
por: Preylowski, Veronika, et al.
Publicado: (2013)

Evaluation of Musculoskeletal and Pulmonary Bacterial Infections With [(124)I]FIAU PET/CT
por: Cho, Steve Y., et al.
Publicado: (2020)

Optimizing reconstruction parameters for quantitative (124)I-PET in the presence of therapeutic doses of (131)I
por: Fanchon, Louise M., et al.
Publicado: (2021)

Calibration of PET/CT scanners for multicenter studies on differentiated thyroid cancer with (124)I
por: Kist, Jakob W., et al.
Publicado: (2016)

Radiosynthesis of no-carrier-added meta-[(124)I]iodobenzylguanidine for PET imaging of metastatic neuroblastoma
por: Green, Michael, et al.
Publicado: (2016)

(18)F-FDG PET/MR versus MR Alone in Whole-Body Primary Staging and Restaging of Patients with Rectal Cancer: What Is the Benefit of PET?
por: Li, Yan, et al.
Publicado: (2020)

Effectiveness of [(124)I]-PET/CT and [(18)F]-FDG-PET/CT for Localizing Recurrence in Patients with Differentiated Thyroid Carcinoma
por: Lee, Jandee, et al.
Publicado: (2012)

The Combination of In vivo (124)I-PET and CT Small Animal Imaging for Evaluation of Thyroid Physiology and Dosimetry
por: El-Ali, Henrik H., et al.
Publicado: (2012)

I-124 Imaging and Dosimetry
por: Kuker, Russ, et al.
Publicado: (2017)

Efficiency of (124)I radioisotope production from natural and enriched tellurium dioxide using (124)Te(p,xn)(124)I reaction
por: Bzowski, Paweł, et al.
Publicado: (2022)

dAcquisition setting optimization and quantitative imaging for (124)I studies with the Inveon microPET-CT system
por: Anizan, Nadège, et al.
Publicado: (2012)

Positron range in combination with point-spread-function correction: an evaluation of different implementations for [124I]-PET imaging
por: Kertész, Hunor, et al.
Publicado: (2022)

(18) F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine
por: Kirchner, Julian, et al.
Publicado: (2017)

(124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy
por: Tijink, Bernard M., et al.
Publicado: (2009)

Iodine-124: A Promising Positron Emitter for Organic PET Chemistry
por: Koehler, Lena, et al.
Publicado: (2010)

Lung Nodules Missed in Initial Staging of Breast Cancer Patients in PET/MRI—Clinically Relevant?
por: Jannusch, Kai, et al.
Publicado: (2022)

[(18)F]FDG PET/MRI in children suffering from lymphoma: does MRI contrast media make a difference?
por: Jannusch, Kai, et al.
Publicado: (2023)

Diagnostic accuracy of (18)F–FDG PET/CT and MR imaging in patients with adenoid cystic carcinoma
por: Ruhlmann, Verena, et al.
Publicado: (2017)

Remote loading of liposomes with a (124)I-radioiodinated compound and their in vivo evaluation by PET/CT in a murine tumor model
por: Engudar, Gokce, et al.
Publicado: (2018)

Free-breathing 3D Stack of Stars GRE (StarVIBE) sequence for detecting pulmonary nodules in (18)F-FDG PET/MRI
por: Bruckmann, Nils Martin, et al.
Publicado: (2022)

Risks and Safety Aspects of MR-PET
por: Brix, Gunnar, et al.
Publicado: (2013)

Correlation between Imaging Markers Derived from PET/MRI and Invasive Acquired Biomarkers in Newly Diagnosed Breast Cancer
por: Jannusch, Kai, et al.
Publicado: (2023)

Multiparametric Integrated (18)F-FDG PET/MRI-Based Radiomics for Breast Cancer Phenotyping and Tumor Decoding
por: Umutlu, Lale, et al.
Publicado: (2021)

Molecular Imaging of Nonsmall Cell Lung Carcinomas Expressing Active Mutant EGFR Kinase Using PET with [(124)I]-Morpholino-IPQA
por: Yeh, Skye Hsin-Hsien, et al.
Publicado: (2013)

First-in-Man Evaluation of (124)I-PGN650: A PET Tracer for Detecting Phosphatidylserine as a Biomarker of the Solid Tumor Microenvironment
por: Laforest, Richard, et al.
Publicado: (2017)

Evaluation of (124)I-JS001 for hPD1 immuno-PET imaging using sarcoma cell homografts in humanized mice
por: Huang, Haifeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hg3atcqp9ma2sijq715gheq130